Eisenmenger syndrome is a chronic condition characterized by advanced pulmonary hypertension associated with congenital heart disease. Cyanotic system like bluish or grayish coloration of skin can be observed in the patients with Eisenmenger syndrome. Chest tightness, pain and shortness of breath, lesions, headaches, dizziness, easily tiring, fainting, numbness or tingling in fingers and/or toes are the most common symptoms. Severe pulmonary arterial hypertension is the basic diagnosis of Eisenmenger syndrome. The diagnosis of Eisenmenger syndrome can be made when the mean pressure in the pulmonary trunk which can be elevated beyond 25 mmHg while at rest and 30 mmHg while at exercising. This elevation is resulted from aggravating thrombotic processes, pulmonary artery remodeling and vasoconstriction. Use of antiarrhythmics, anticoagulants, diuretics and/or digitalis is included in the pharmacological treatment. The management aspects include behavioral modifications, awareness of potential medical risk factors and patient education. The drugs for pulmonary hypertension have not been modified the survival rate significantly yet. The prevention by early surgery is ideal, as little progress in management has been made. Progressive factors like high altitudes, anesthesia, estrogen contraception and pregnancy has to be avoided. Cooperation of the medical practitioners with specialists like cardiologists and awareness about complications should improve the patient’s outlook.
Loading....